(IBDS) iShares iBonds Dec 2027 - Ratings and Ratios
Corporate Bonds, Investment Grade, 2027 Maturity, USD
Dividends
| Dividend Yield | 4.35% |
| Yield on Cost 5y | 4.57% |
| Yield CAGR 5y | 9.39% |
| Payout Consistency | 95.1% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 1.38% |
| Value at Risk 5%th | 2.07% |
| Relative Tail Risk | -8.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 1.32 |
| CAGR/Max DD | 1.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.406 |
| Beta | 0.015 |
| Beta Downside | -0.002 |
| Drawdowns 3y | |
|---|---|
| Max DD | 3.28% |
| Mean DD | 0.60% |
| Median DD | 0.31% |
Description: IBDS iShares iBonds Dec 2027 November 09, 2025
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is a target-maturity fund that must allocate at least 80 % of its net assets to the securities that make up its underlying index and at least 90 % to fixed-income instruments of the same type. The index tracks U.S.-dollar-denominated, investment-grade corporate bonds that all mature in 2027.
Key metrics as of the latest reporting period show an average effective duration of roughly 4.8 years and a weighted-average credit rating near AA, indicating relatively low default risk. The fund’s yield to maturity is currently around 4.4 %, reflecting the prevailing 10-year Treasury rate plus a modest credit spread. Sector exposure is diversified, with the largest allocations to industrials, consumer discretionary, and technology, which together account for about 45 % of holdings.
For a deeper dive into IBDS’s projected cash-flow profile and sector-level credit risk, the ValueRay platform provides detailed analytics that can help you assess whether the fund aligns with your risk-return objectives.
What is the price of IBDS shares?
Over the past week, the price has changed by +0.12%, over one month by +0.28%, over three months by +1.21% and over the past year by +5.34%.
Is IBDS a buy, sell or hold?
What are the forecasts/targets for the IBDS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.1 | 7.1% |
IBDS Fundamental Data Overview November 19, 2025
Beta = 0.56
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.44b USD (3.44b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.44b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.44b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.07% (E(3.44b)/V(3.44b) * Re(6.07%) + (debt-free company))
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBDS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle